Gain Therapeutics Inc (GANX)
3.065
-0.12
(-3.92%)
USD |
NASDAQ |
Apr 25, 10:18
Gain Therapeutics Price to Book Value: 3.952 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 4.114 |
| April 23, 2024 | 4.371 |
| April 22, 2024 | 4.088 |
| April 19, 2024 | 4.101 |
| April 18, 2024 | 4.062 |
| April 17, 2024 | 4.101 |
| April 16, 2024 | 4.075 |
| April 15, 2024 | 3.985 |
| April 12, 2024 | 4.062 |
| April 11, 2024 | 4.333 |
| April 10, 2024 | 4.307 |
| April 09, 2024 | 4.358 |
| April 08, 2024 | 4.423 |
| April 05, 2024 | 4.591 |
| April 04, 2024 | 4.616 |
| April 03, 2024 | 5.145 |
| April 02, 2024 | 5.016 |
| April 01, 2024 | 4.939 |
| March 28, 2024 | 4.861 |
| March 27, 2024 | 4.810 |
| March 26, 2024 | 4.900 |
| March 25, 2024 | 4.707 |
| March 22, 2024 | 5.235 |
| March 21, 2024 | 5.635 |
| March 20, 2024 | 5.493 |
| Date | Value |
|---|---|
| March 19, 2024 | 5.480 |
| March 18, 2024 | 5.622 |
| March 15, 2024 | 5.532 |
| March 14, 2024 | 5.519 |
| March 13, 2024 | 5.854 |
| March 12, 2024 | 5.880 |
| March 11, 2024 | 6.022 |
| March 08, 2024 | 6.099 |
| March 07, 2024 | 5.932 |
| March 06, 2024 | 6.074 |
| March 05, 2024 | 6.009 |
| March 04, 2024 | 6.086 |
| March 01, 2024 | 6.035 |
| February 29, 2024 | 5.790 |
| February 28, 2024 | 5.747 |
| February 27, 2024 | 5.966 |
| February 26, 2024 | 5.798 |
| February 23, 2024 | 5.863 |
| February 22, 2024 | 5.721 |
| February 21, 2024 | 5.695 |
| February 20, 2024 | 6.017 |
| February 16, 2024 | 6.210 |
| February 15, 2024 | 6.185 |
| February 14, 2024 | 6.094 |
| February 13, 2024 | 5.811 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9558
Minimum
May 24 2022
26.79
Maximum
Mar 30 2021
3.199
Average
2.553
Median
Price to Book Value Benchmarks
| Eli Lilly and Co | 63.98 |
| Alpine Immune Sciences Inc | 12.92 |
| Outlook Therapeutics Inc | -- |
| Greenwich LifeSciences Inc | 23.87 |
| CEL-SCI Corp | 6.145 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0578 |
| Price | 3.065 |
| Earnings Yield | -55.79% |
| Market Cap | 49.71M |
| PEGY Ratio | -0.0578 |